Vaxart, Inc.
VXRT
$0.4945
-$0.038-7.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 857.18% | 367.95% | 134.79% | 371.35% | 223.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 857.18% | 367.95% | 134.79% | 371.35% | 223.11% |
| Cost of Revenue | 61.70% | 54.06% | 0.43% | -7.09% | -3.10% |
| Gross Profit | 41.37% | 34.83% | 21.46% | 36.53% | 11.16% |
| SG&A Expenses | -29.99% | -26.05% | -11.77% | -7.52% | 9.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.42% | 32.42% | -2.58% | -7.19% | 0.02% |
| Operating Income | 37.95% | 32.00% | 18.78% | 29.48% | 5.87% |
| Income Before Tax | 36.42% | 31.35% | 19.00% | 27.01% | 2.94% |
| Income Tax Expenses | 111.11% | 1.15% | -53.85% | 10.53% | 55.17% |
| Earnings from Continuing Operations | 36.15% | 31.02% | 19.08% | 26.98% | 2.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.15% | 31.02% | 19.08% | 26.98% | 2.88% |
| EBIT | 37.95% | 32.00% | 18.78% | 29.48% | 5.87% |
| EBITDA | 42.05% | 36.47% | 22.25% | 32.77% | 6.88% |
| EPS Basic | 52.70% | 56.98% | 45.94% | 44.83% | 22.22% |
| Normalized Basic EPS | 52.88% | 57.26% | 45.94% | 44.90% | 22.31% |
| EPS Diluted | 52.70% | 56.98% | 45.94% | 44.27% | 22.22% |
| Normalized Diluted EPS | 52.88% | 57.26% | 45.94% | 44.90% | 22.31% |
| Average Basic Shares Outstanding | 35.02% | 60.44% | 49.61% | 32.31% | 24.85% |
| Average Diluted Shares Outstanding | 35.02% | 60.44% | 49.61% | 32.31% | 24.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |